Skip to main content

HLN · Haleon plc · Proposed Sales

Track HLN — free
$9.19 -0.03 (-0.33%) At close · Sep 11
Market Cap
$40.41B
Shares
4.40B

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2023-12-29 GlaxoSmithKline (US) Trust 8,527,104
2023-12-05 GSK Master Grantor Trust 404,599
2023-11-03 GlaxoSmithKline Employee Trust 173,611
Showing 1–3 of 3 filings
Key facts CIK 1900304 CUSIP 405552100 13F (30d) 191 filings 185 filers Visit website Investor relations